Investor Relations

OPKO Surpasses 50% Enrollment in First Phase 3 Trial of RayaldyTM (CTAP101 Capsules) more »

OPKO Announces First Quarter 2013 Operating and Financial Highlights more »

OPKO Health To Acquire PROLOR Biotech more »

OPKO Health Acquires Interest in Growing Russian Pharmaceutical Company more »

Corporate Governance

The Board of Directors of OPKO Health, Inc. (the "Company") sets high standards for the Company's employees, officers, and directors. Implicit in this philosophy is the importance of sound corporate governance. It is the duty of the Board of Directors to serve as a prudent fiduciary for shareholders and to oversee the management of the Company's business.

Communications with the Board

Stockholders and all interested parties may initiate in writing any communication with our Board of Directors, the presiding member of the non-management directors, or any individual director by sending the correspondence to OPKO Health, Inc., 4400 Biscayne Blvd., Miami, Florida 33137, Attention: Secretary. This centralized process assists our Board of Directors in reviewing and responding to communications in an appropriate manner. If a stockholder or any interested party would like the letter to be forwarded directly to one of the Chairmen of the three standing committees of the Board, he or she should so indicate. If no specific direction is indicated, the Secretary's office will review the letter and forward it to the appropriate Board member(s).


OPKO Management and Board of Directors
» Board of Directors
» Management Team

Document View
Audit Committee Charter   PDF   33.3 KB  
Compensation Committee Charter   PDF   35.1 KB  
Governance and Nominating Committee Charter   PDF   32.4 KB  
Code of Business Conduct and Ethics HTML PDF   48.6 KB  
Corporate Governance Guidelines   PDF   28.0 KB